Please login to the form below

Not currently logged in
Email:
Password:

Atlas Venture

This page shows the latest Atlas Venture news and features for those working in and with pharma, biotech and healthcare.

Biogen buys into Rodin's Alzheimer's candidate

Biogen buys into Rodin's Alzheimer's candidate

And may acquire the epigenetics-focused Massachusetts firm. Biogen has signed a deal with Atlas Venture-backed Rodin Therapeutics that could result in the acquisition of the Alzheimer's disease-focused ... Biogen and Atlas are stumping up $17m to help

Latest news

  • Novartis signs stem cell research pact with Intellia Novartis signs stem cell research pact with Intellia

    This collaboration comes just three months after Intellia was launched by Atlas Venture and Caribou Biosciences, who both gave $15m to the start-up as well as an initial financial backing

  • Amgen and Novartis partner with biotech venture capital firm

    Atlas Venture fund aims to create 15 new biotech companies. Biotech venture capital firm Atlas Venture has added Novartis and Amgen to its list of partners. ... The deal means both Amgen and Novartis become limited partners of the Atlas IX – a fund

  • f-star wins €15m investment

    The investment initiative was led by SR One, the corporate venture capital arm of GlaxoSmithKline. ... All of f-star's existing investors, Atlas Venture, Aescap Venture, Novo Ventures, TVM Capital, Merck Serono Ventures and MP Healthcare Venture

  • BMS pays USD 430m for biotech firm

    Adnexus is a privately held Delaware corporation that was formed in 2003 by investors including Atlas Venture, Flagship Ventures and Polaris Venture Partners.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Pharma deals during May 2013 Pharma deals during May 2013

    The financial terms were not disclosed but it seems that Shire's alliance with Atlas Ventures is bearing fruit. ... Another venture captial company, Novo A/S, the company that manages the $30bn assets of the Novo Nordisk Foundation, has also made a

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...